MLCOT Stock Overview
Gour Medical SA, a pharmaceutical development company, engages in the development and marketing of various veterinary solutions for pets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Gour Medical SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.08 |
| 52 Week High | €0.08 |
| 52 Week Low | €0.005 |
| Beta | -0.85 |
| 1 Month Change | 15.11% |
| 3 Month Change | 300.00% |
| 1 Year Change | 100.00% |
| 3 Year Change | -23.81% |
| 5 Year Change | -91.58% |
| Change since IPO | -98.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLCOT | FR Pharmaceuticals | FR Market | |
|---|---|---|---|
| 7D | 14.3% | -1.6% | -0.03% |
| 1Y | 100.0% | -14.5% | 1.8% |
Return vs Industry: MLCOT exceeded the French Pharmaceuticals industry which returned -14% over the past year.
Return vs Market: MLCOT exceeded the French Market which returned 1.7% over the past year.
Price Volatility
| MLCOT volatility | |
|---|---|
| MLCOT Average Weekly Movement | 55.3% |
| Pharmaceuticals Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: MLCOT's share price has been volatile over the past 3 months.
Volatility Over Time: MLCOT's weekly volatility (55%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Serge Goldner | www.gour-medical.com |
Gour Medical SA, a pharmaceutical development company, engages in the development and marketing of various veterinary solutions for pets. It provides cannabidiol solutions for pets under the WEEDLEY brand. The company was founded in 2014 and is headquartered in Paris, France.
Gour Medical SA Fundamentals Summary
| MLCOT fundamental statistics | |
|---|---|
| Market cap | €1.07m |
| Earnings (TTM) | -€56.14k |
| Revenue (TTM) | €1.00 |
Over9,999x
P/S Ratio-19.1x
P/E RatioIs MLCOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLCOT income statement (TTM) | |
|---|---|
| Revenue | €1.00 |
| Cost of Revenue | €1.05k |
| Gross Profit | -€1.05k |
| Other Expenses | €55.09k |
| Earnings | -€56.14k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0042 |
| Gross Margin | -105,200.00% |
| Net Profit Margin | -5,614,200.00% |
| Debt/Equity Ratio | -28.8% |
How did MLCOT perform over the long term?
See historical performance and comparison